HOW SHOULD WE SUPPORT PATIENTS WITH PRIMARY BRAIN TUMOURS WHO ELECT TO TAKE CANNABINOIDS?

INTRODUCTION: Primary brain tumours account for 3% of new cancer cases (2015) but account disproportionately in terms of mortality and morbidity. With radical treatment prognosis is variable; ranging from 80% survival for 5 years or more for benign meningiomas to a dismal 5% for Glioblastoma multifo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: La, Jessica, Hurwitz, Victoria, Mullens, Laura, Brazil, Lucy, Gullan, Richard, Bhangoo, Ranj, Vergani, Francesco, Beaney, Ronald, Ashkan, Keyoumars, Rooprai, Bali, Swampillai, Angela
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2018
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6168826/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy129.028
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados